1. Home
  2. TRUP vs KROS Comparison

TRUP vs KROS Comparison

Compare TRUP & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRUP
  • KROS
  • Stock Information
  • Founded
  • TRUP 2000
  • KROS 2015
  • Country
  • TRUP United States
  • KROS United States
  • Employees
  • TRUP N/A
  • KROS N/A
  • Industry
  • TRUP Medical Specialities
  • KROS Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRUP Health Care
  • KROS Health Care
  • Exchange
  • TRUP Nasdaq
  • KROS Nasdaq
  • Market Cap
  • TRUP 2.3B
  • KROS 1.8B
  • IPO Year
  • TRUP 2014
  • KROS 2020
  • Fundamental
  • Price
  • TRUP $52.76
  • KROS $56.62
  • Analyst Decision
  • TRUP Buy
  • KROS Strong Buy
  • Analyst Count
  • TRUP 7
  • KROS 8
  • Target Price
  • TRUP $44.67
  • KROS $91.43
  • AVG Volume (30 Days)
  • TRUP 634.6K
  • KROS 383.1K
  • Earning Date
  • TRUP 10-30-2024
  • KROS 11-06-2024
  • Dividend Yield
  • TRUP N/A
  • KROS N/A
  • EPS Growth
  • TRUP N/A
  • KROS N/A
  • EPS
  • TRUP N/A
  • KROS N/A
  • Revenue
  • TRUP $1,244,234,000.00
  • KROS $651,000.00
  • Revenue This Year
  • TRUP N/A
  • KROS $1,232.45
  • Revenue Next Year
  • TRUP $6.66
  • KROS $126.39
  • P/E Ratio
  • TRUP N/A
  • KROS N/A
  • Revenue Growth
  • TRUP 17.52
  • KROS 8037.50
  • 52 Week Low
  • TRUP $19.69
  • KROS $27.31
  • 52 Week High
  • TRUP $57.90
  • KROS $73.00
  • Technical
  • Relative Strength Index (RSI)
  • TRUP 55.51
  • KROS 38.94
  • Support Level
  • TRUP $51.24
  • KROS $65.54
  • Resistance Level
  • TRUP $55.88
  • KROS $70.26
  • Average True Range (ATR)
  • TRUP 2.99
  • KROS 3.17
  • MACD
  • TRUP -0.30
  • KROS -0.64
  • Stochastic Oscillator
  • TRUP 45.78
  • KROS 9.07

About TRUP Trupanion Inc.

Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue primarily from subscription fees related to the Company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: